Cart
sales@molnova.com
HPK1-IN-2
CAS No. 2056122-11-1
HPK1-IN-2( Thieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2 )
Catalog No. M23923 CAS No. 2056122-11-1
HPK1-IN-2 is a potent and orally active inhibitor of hematopoietic progenitor kinase-1 (HPK1;IC50<0.05 μΜ).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 164 | In Stock |
|
| 5MG | 139 | In Stock |
|
| 10MG | 231 | In Stock |
|
| 25MG | 386 | In Stock |
|
| 50MG | 537 | In Stock |
|
| 100MG | 714 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHPK1-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionHPK1-IN-2 is a potent and orally active inhibitor of hematopoietic progenitor kinase-1 (HPK1;IC50<0.05 μΜ).
-
DescriptionHPK1-IN-2 is a potent and orally active inhibitor of hematopoietic progenitor kinase-1 (HPK1;IC50<0.05 μΜ). It also inhibits Lck (0.05 μΜIn Vitro——In Vivo——SynonymsThieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2PathwayAngiogenesisTargetFLTRecptorFlt3|HPK1|LckResearch Area——Indication——
Chemical Information
-
CAS Number2056122-11-1
-
Formula Weight380.47
-
Molecular FormulaC19H20N6OS
-
Purity>98% (HPLC)
-
SolubilityH2O:25 mg/mL?(55.14 mM;?Need ultrasonic)
-
SMILESO=C1C(C2=NC3=CC=C(N4CCN(C)CC4)C=C3N2)=C(N)C(C=CS5)=C5N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peter Brent Sampson, et al. Hpk1 inhibitors and methods of using same. WO2016205942A1.
molnova catalog
related products
-
FLT3-IN-3
FLT3-IN-3 is an effective FLT3 inhibitor, and the IC50s of FLT3 WT and FLT3 D835Y are 13 and 8 nM, respectively.
-
HM43239
HM43239 is a selective FLT3 inhibitor (IC50s: 1.1 nM for FLT3 WT, 1.8 nM for FLT3 ITD, and 1.0 nM for FLT3 D835Y kinases, respectively).
-
HM43239 B
HM43239 is an orally active and selective FLT3 inhibitor with IC 50 s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively.
